- Health A to Z
Healthline Premium Tools
Advertisement
Marketplace
|
The month of September hasn't always been kind to the Witte family.In September 2003, Don Witte was diagnosed with renal cell cancer.
|
|
The U.S. Food and Drug Administration's review staff expressed doubts that GlaxoSmithKline Plc's experimental kidney cancer drug Votrient should be approved given concerns about liver injury, documents released on Thursday said.
|
|
The FDA Advisory Committee will discuss pazopanib tablets, manufactured by GlaxoSmithKline.
|
|
A Metairie man says he's lucky, even though he has a serious form of cancer. First, he's lucky for the reason he initially went to the doctor, and second, because he lives right here in this area, where a groundbreaking treatment was pioneered.
|
|
Afinitor Now Licensed In UK For Advanced Kidney Cancer Patients After Failure Of First Line Vascular Targeted Therapy Main Category: Urology / Nephrology Also Included In: Cancer / Oncology Regulatory Affairs / Drug Approvals Afinitor has recently been licensed for the treatment of advanced kidney cancer after failure of treatments which prevent ...
|
|
Swiss drug developer Roche said Friday six cases of patients with heart failure symptoms prompted a halt to enrollment in a National Cancer Institute sponsored study of its blockbuster drug Avastin.
|
|
If you want to get insights into the problems of our health care system, you should certainly listen to policy makers like Peter Orzag, browse economist Uwe Rhinehardt's blog, or read Atul Gawande's recent article in the New Yorker.
|
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2009 Healthline Networks, Inc. All rights reserved.